One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Obinutuzumab for the management of immune-mediated glomerular diseases Free
doi : 10.1093/ndt/gfaf021
Volume 40, Issue 8, August 2025
More versus less intensive blood pressure reduction and kidney function outcomes—Waiting for Godot? Free
doi : 10.1093/ndt/gfaf034
PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy Open Access
doi : 10.1093/ndt/gfaf012
The autonomic nervous system and inflammation in chronic kidney disease Free
doi : 10.1093/ndt/gfaf020
Music-based interventions in mild cognitive impairment and kidney disease: a scoping review on behalf of CONNECT (Cognitive decline in Nephro-Neurology European Cooperative Target) action Free
doi : 10.1093/ndt/gfaf041
Maintaining kidney health in aging societies: a JSN and ERA call to action Open Access
doi : 10.1093/ndt/gfaf068
Incidence of acute kidney injury in relapsed and refractory multiple myeloma treated with teclistamab versus CAR-T cells Free
doi : 10.1093/ndt/gfaf004
Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome Free
doi : 10.1093/ndt/gfaf011
A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1 Free
doi : 10.1093/ndt/gfaf016
Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis Free
doi : 10.1093/ndt/gfaf017
Low birth weight and chronic kidney disease with progression to kidney failure in children Free
doi : 10.1093/ndt/gfaf018
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics Open Access
doi : 10.1093/ndt/gfaf022
Red blood cell casts on kidney biopsy and progression of IgA nephropathy Free
doi : 10.1093/ndt/gfaf023
Access to kidney transplantation and re-transplantation from childhood to adulthood: long-term data from the ERA Registry Open Access
doi : 10.1093/ndt/gfaf025
Haemodiafiltration versus high-flux haemodialysis—a Consensus Statement from the EuDial Working Group of the ERA Open Access
doi : 10.1093/ndt/gfaf024
IdeZ protease does not prevent convertase stabilization by C3 nephritic factors in C3 glomerulopathy Open Access
doi : 10.1093/ndt/gfaf065
Prevalence and characteristics of chronic kidney disease in the Hamburg City Health Study Open Access
doi : 10.1093/ndt/gfaf075
Correction to: Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD Free
doi : 10.1093/ndt/gfaf096
Correction to: Upcoming drug targets for kidney protective effects in chronic kidney disease Open Access
doi : 10.1093/ndt/gfaf099
Correction to: Hypocalcemia and cardiovascular mortality in cinacalcet users
doi : 10.1093/ndt/gfaf100
